Artroskopik diz cerrahisinde intratekal ropivakainin üç farklı dozunun anestezi kalitesi ve postoperatif analjeziye etkileri

Amaç: Artroskopik diz cerrahisi vakalarında intratekal uygulanan %0.75 izobarik ropivakainin 10,12.5 ve 15 mg'lık dozlarının oluşturduğu analjezi ve anestezi kalitesi araştırıldı. Yöntem: Elektif artroskopik diz cerrahisi geçirecek ASA I-II grubundan 60 hasta rast gele 20'şer kişilik 3 gruba ayrıldı. Standart monitör izasy on sonrası %0.75'lik ropivakain, total volüm 2 mL olacak şekilde %0.9 serum fizyolojik ile tamamlanıp, Grup Ve 10 mg (%0.5), Grup IV ye 12.5 mg (%0.625) ve Grup III' e 15 mg (%0.75) uygulandı. Duyusal bloğun maksimal üst seviyeye ve T10'a ulaşma, analjezi düzeyinin iki segment ve Tıo dermatomuna gerileme süresi kaydedildi. Motor bloğun derecesi, süresi ve sonlanma zamanı not edildi. Postoperatif hasta ve cerrahın memnuniyet dereceleri sorgulandı. Postoperatif ilk ağrı başlama zamanı ve ağrı skorları, ilk analjezik, yürüme ve miksiyon zamanlan kaydedildi. Bulgular: Üç grupta da maksimal duyu bloğunun oluşma süresi eşit bulundu. Duyu bloğunun iki segment gerilemesi ve tamamen kalkması, motor blok sonlanması ve ilk analjezik ihtiyaç süresi Grup III'de Grup Ve göre anlamlı uzundu. Vital bulguların zama­na bağlı değişimleri ve intraoperatif yan etkiler, ilk yürüme ve idrar yapma zamanları açısından gruplar arasında fark yoktu. Sonuç: Günübirlik artroskopik diz cerrahisi vakalarında oturur pozisyonda uygulanan 10 mg (%0.5) intratekal ropivakainin sağladığı anestezi ve analjezi kalitesinin yeterli olduğu kanısına varıldı.

The anesthetic quality and postoperative analgesic effects of three different doses of spinal ropivacaine in arthroscopic knee surgery

Objective: The anesthesia and analgesia of 10,12.5 and 15 mg doses of intrathecal ropivacaine were compared in arthroscopic knee surgery patients. Method: Sixty patients with ASA physical status I-II and scheduled for elective arthroscopic surgery were randomized into 3 groups of 20 patients. After standard monitorization, 10 mg (0.5%), 12.5 mg (0.625%) and 15 mg (0.75%) doses of 0.75% ropivacaine were administered intrathecally in Group I, II and III respectively. Maximum sensory block, the time to T10 sensory block, the time necessary for two segment regression and the regression to T10 dermatome time were recorded. Grade, duration and ending time of motor block were evaluated. Postoperatively, patient and surgeon satisfaction were noted. Postoperative first pain sensation time and VAS scores, first analgesic requirement, first mobilization and first micturation time were recorded. Results: Maximum sensorial block time was similar between the three groups. Two dermatomal regression, complete recovery time of sensorial block, complete recovery of motor block and the first analgesic requirements were significantly longer in Group III than in Group I. Changes in the vital signs, intraoperative side effects, first mobilization and micturation times were similar in all groups. Conclusion: Intrathecal anesthesia and analgesia quality with 10 mg (0.5%) ropivacaine were sufficient for ambulatory arthroscopic knee surgery.

___

  • 1. Morgan GE, Mikhail MS, Murray MJ (ed). Anesthesia for Orthopedic Surgery. In: Clinical Anesthesiology. (3rd ed) Appleton & Lange, Los Angeles, 2002: 782-792.
  • 2. Morgan GE, Mikhail MS, Murray MJ (ed). Outpatient Anesthesia. In: Clinical Anesthesiology. (3rd ed) Appleton & Lange, Los Angeles, 2002: 882-888.
  • 3. Wille M. Intrathecal use of ropivacaine: a review. Acta Anaesthesiol Belg 2004; 55: 251-9.
  • 4. Grass AJ. New Developments in Spinal Anesthesia. Anesthesiol Clin North America, Regional Anesthesia. 2000: 235-50.
  • 5. Liu SS, McDonald SB. Current issues in spinal anesthesia. Anesthesiology 2001; 94: 888-906.
  • 6. Cappelleri G, Aldegheri G, Danelli G ve ark. Spinal anesthesia with hyperbaric levobupivacaine and ropivacaine for outpatient knee arthroscopy: a prospective, randomized, double-blind study. Anesth Analg 2005; 101: 77-82.
  • 7. Gautier E, De Kock M, Van Steenberge A, Poth N, Lahaye-Goffart B, Fanard L, Hody JL. Intrathecal ropivacaine for ambulatory surgery. Anesthesiology 1999; 91: 1239-45.
  • 8. Kayhan Z. Santral Bloklar, Spinal ve Epidural Anestezi. In: Klinik Anestezi, 3. baskı. Logos Yayıncılık, İstanbul 2005, 552-589.
  • 9. Morgan GE, Mikhail MS, Murray MJ (ed). Pain Management. Clinical Anesthesiology. 3rd edition Appleton & Lange Los Angeles 2002: 309-358.
  • 10. McNamee DA, Parks L, McCelland AM, Scott S, Milligan KR, Ahlen K, Gustafsson U. Intrathecal ropivacaine for total hip surgery for total hip arthroplasty: double-blind comperative study with isobaric 7.5 mg ml-1 and 10 mg ml-1 solutions. Br J Anaesth 2001; 87: 743-7.
  • 11. Kallio H, Snall EV, Kero MP, Rosenberg PH. A comparison of intrathecal plain solutions containing ropivacaine 20 or 15 mg versus bupivacaine 10mg. Anesth Analg 2004; 99: 713-7.
  • 12. Fettes PD, Hocking G, Peterson MK, Luck JF, Wildsmith JA. Comparison of plain and hyperbaric solutions of ropivacaine for spinal anesthesia. Br J Anaesth 2005; 94: 107-11.
  • 13. De Kock M, Gautier P, Fanard L, Hody JL, Lavand’homme P. Intrathecal ropivacaine and clonidine for ambulatory knee artroscopy: a dose- response study. Anesthesiology 2001; 94: 574-8.
  • 14. Sell A, Olkkola KT, Jalonen J, Aantaa R. Minimum effective local anaesthetic dose of isobaric levobupivacaine and ropivacaine administered via a spinal catheter for hip replacement surgery. Br J Anaesth 2005; 94: 239-42.
  • 15. Camorcia M, Capogna G, Lyons G, Columb MO. Epidural test dose with levobupivacaine and ropivacaine: determination of ED50 motor block after spinal administration. Br J Anaesth 2004; 92: 850-3.
  • 16. Khaw KS, Kee WD, Wong M, Ng F, Lee A. Spinal ropivacaine for cesarean delivery:a comparison of hyperbaric and plain solutions. Anesth Analg 2002; 94: 680-5.
  • 17. Kallio H, Snall EV, Tuomas CA, Rosenberg PH. Comparison of hyperbaric and plain ropivacaine 15 mg in spinal anaesthesia for lower limb surgery. Br J Anaesth 2004; 93: 664-9.